Arkolith/Insider Trading/BRTX/Form 4

Alstodt Lance

President, CEO, COB, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Dec 28, 2022
Net Buying
Open-Market Buys
$903
Open-Market Sells
$0
Net Open-Market Flow
$903
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2022Buy(P)100$2.99$299186K
Dec 23, 2022Buy(P)200$3.02$604186K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-022055) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML